#Cannapharmarx CPMD

[fmarkets]

Cannapharmarx'Inc's'Revenue'Soars'to'''''''''''Million'in'Latest'Financial'Report $CPMD #Stockmarket #OTCM

Financial Analyst Raises Concerns Over Cannapharmarx Inc's $-11.716 Million Net ShortfallAs a financial analyst for the CSIMarket.com, I have been closely monitoring the latest financial results of Major Pharmaceutical Preparations company and Cannapharmarx Inc. The Major Pharmaceutical Preparations company has reported $0.025839 million in revenue for the financial interval ending March 31, 2024. This signifies a steady growth in their earnings and reflects positively on their business operations. However, Cannapharmarx Inc has faced

[420tokens-us]

IRVINE, Calif., Jan. 8, 2019 /PRNewswire/ -- Cannapharmarx, Inc. (OTC Pink Sheets: "CPMD") announced today it has completed the acquisition of Alternative Medical Solutions, Inc., ("AMS"), an Ontario, Canada corporation. Under the terms of the agreement Hanover CPMD Acquisition Corp

[gary-herick]

CannaPharmaRx Announces the Acquisition of a Minority Interest in GN Ventures

CannaPharmaRx Announces the Acquisition of a Minority Interest in GN Ventures

CannaPharmaRx Announces the Acquisition of a Minority Interest in GN Ventures, a Canadian Cannabis Producer, and the Appointment of Dominic Colvin as CEO and Chairman of the Board

Company Continues to acquire Cannabis Grow Capacity in Canada

IRVINE, Calif., Feb 28, 2019 (GLOBE NEWSWIRE via COMTEX) — IRVINE, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) — CannaPharmaRx, Inc.(otc pink sheets:”CPMD”)…

[otcsocialnetwork]

7/19/22 TRENDS

$XELA Exela Technologies $NSAV NET SAVINGS LINK INC $CZNI CRUZANI INC $TXTM PROTEXT MOBILITY INC $RNVA Rennova Health, Inc $MULN Mullen Automotive, Inc $TBLT ToughBuilt Industries $APLD Applied Blockchain $HMBL HUMBL INC $PHIL PHI GROUP INC $IMPP Imperial Petroleum Inc $WDLF SOCIAL LIFE NETWORK INC $CEI Camber Energy $AITX Artificial Intelligence Technology Solutions $KYNC KYN CAPITAL GROUP INC $NFLX Netflix $INND INNERSCOPE HEARING TECHNOLOGIES $AABB ASIA BROADBAND INC $SNDL Sundial Growers $WBBA WB BURGERS ASIA INC $MARA Marathon Digital Holdings $BKKT Bakkt Holdings, Inc $GOEV Canoo Holdings $AMC AMC Entertainment Holdings $DPLS DARKPULSE INC $GDX VanEck Vectors Gold Miners ETF $LITOF FRONTIER LITHIUM INC $BAOS Baosheng Media Group $CPMD CANNAPHARMARX $SQQQ ProShares Trust $SUNW Sunworks $F Ford Motor Company $PBR Petroleo Brasileiro S.A $QBAN TELCO CUBA INC $CVM CEL-SCI Corporation $OTRK Ontrak, Inc $SPY S&P 500 Index – “Spiders $STIM NEURONETICS $MAXD Max Development Inc $AKTX Akari Therapeutics Plc $TANH Tantech Holdings $FONU FONU2 INC $MJWL MAJIC WHEELS CORP $MREO Mereo BioPharma Group $LCLP LIFE CLIPS INC $RIOT Riot Blockchain $QNGY Quanergy Systems $NCNA NuCana plc $NWBO Northwest Biotherapeutics $BBIG Vinco Ventures, Inc http://dlvr.it/SV9VsH

[fmarkets]

Cannapharmarx Inc Dominates Third Quarter of 2023, Outperforming Competitors with Impressive Results https://csimarket.com/stocks/news.php?code=CPMD&date=2023-11-18115954&utm_source=dlvr.it&utm_medium=tumblr

[fmarkets]

$CPMD #OTCM Cannapharmarx Inc Dominates Third Quarter of 2023, Outperforming Competitors with Impressive Results

[fmarkets]

$CPMD #Major Pharmaceutical Preparations #OTCM Cannapharmarx Inc Sees Strong Business Growth in Q2 of 2023 Financial Period

[fmarkets]

Cannapharmarx Inc Sees Strong Business Growth in Q2 of 2023 Financial Period https://csimarket.com/stocks/news.php?code=CPMD&date=2023-10-14183902&utm_source=dlvr.it&utm_medium=tumblr

[stocktweetsnews]

roaring_pussy: $CPMD 🚨 Cannapharmarx, Inc. 2021 Current Report 8-K

$CPMD 🚨 Cannapharmarx, Inc. 2021 Current Report 8-K https://t.co/3ToVrWfPdF

— Roaring_Pussy (@roaring_pussy) July 16, 2021

from https://twitter.com/roaring_pussy/status/1416105773642420224

[gary-herick]

CannapharmaRx, Inc., Strengthens Management Team

CannapharmaRx, Inc., Strengthens Management Team

May 14, 2019 – 1:35 PM EDT

CannapharmaRx, Inc., Strengthens Management Team CALGARY, AB / ACCESSWIRE / May 14, 2019 / CannaPharmaRx, Inc. (OTC PINK: CPMD) CannapharmaRx, Inc. (”CPMD” or the ”Company”) is pleased to announce the strengthening of its management team via the recent hires of John Cassels as Chief Financial Officer and Andrew Steedman as Executive Vice President of Business…

[gary-herick]

Sunniva Inc. Agrees To Sell Its Okanagan Falls Property To CannaPharmaRx, Inc. for CAD $20 Million

Sunniva Inc. Agrees To Sell Its Okanagan Falls Property To CannaPharmaRx, Inc. for CAD $20 Million

Sunniva and CannaPharmaRx have entered into an agreement for Sunniva sell Sunniva Medical Inc. to CannaPharmaRx.

June 12, 2019

Transaction is Subject to Financial Audit and Satisfaction of Other Conditions

VANCOUVER, BC / ACCESSWIRE / June 12, 2019 / Sunniva Inc. (“Sunniva”) (SNN; SNNVF) and CannaPharmaRx, Inc. (“CannaPharmaRx”) (OTC PINK: CPMD) are pleased to announce that they have entered…

[otcsocialnetwork]

Top 100 Most Expensive OTC CBD Stocks

Symbol Name Last Price $CWBHF CHARLOTTES WEB HOLDINGS INC 14.6 $GWPRF GW PHARMACEUTICALS 13.98 $GTBIF GREEN THUMB INDUSTRIES INC 11.1425 $CRLBF CRESCO LABS INC 10.28 $ABAHF ABACUS HEALTH PRODUCTS INC 7.43 $CURLF CURALEAF HOLDINGS INC 7.17 $BTTR BETTER CHOICE COMPANY INC 6.35 $HRVSF HARVEST HEALTH AND RECREATION I 6.1727 $CURR CURE PHARMACEUTICAL HOLDING COR 5.2 $KSHB KUSHCO HOLDINGS INC 5.07 $CVSI CV SCIENCES INC 4.065 $MDXG MIMEDX GROUP INC 4.05 $CLGN COLLPLANT BIOTECHNOLOGIES LTD. 4 $MEDIF MEDIPHARM LABS CORP 3.96 $ITHUF IANTHUS CAPITAL HOLDINGS INC 3.377 $GRWG GROWGENERATION CORP 3.3 $COSM COSMOS HOLDINGS INC 3.2 $ORGIF ORGANIGRAM HOLDINGS INC 3.03 $PBIO PRESSURE BIOSCIENCES INC 3 $PLPRF PLUS PRODUCTS INC 2.8 $ELLXF ELIXINOL GLOBAL LTD 2.61 $MMNFF MEDMEN ENTERPRISES INC 2.601 $TGODF GREEN ORGANIC DUTCHMAN HLDGS LT 2.48 $GNBT GENEREX BIOTECHNOLOGY CORP 2.39 $PHBI PHARMAGREEN BIOTECH INC 2.22 $GGBXF GREEN GROWTH BRANDS INC 2.18 $SNNVF SUNNIVA INC 2.0872 $MRMD MARIMED INC 2.02 $PLNHF PLANET 13 HOLDINGS INC 2 $EMHTF EMERALD HEALTH THERAPEUTICS INC 1.84 $KHRNF KHIRON LIFE SCIENCES CORP 1.74 $SOLCF SOL GLOBAL INVESTMENTS CORP 1.6925 $ACBD ANNABIDIOL CORP 1.58 $INNV INNOVUS PHARMACEUTICALS INC 1.52 $UPPR UPPER STREET MARKETING INC 1.5 $CADMF CHEMESIS INTERNATIONAL INC 1.4915 $CPMD CANNAPHARMARX INC 1.43 $CBDS CANNABIS SATIVA INC 1.35 $STMH STEM HOLDINGS INC 1.21 $SPRWF SUPREME CANNABIS CO INC 1.2 $ICNB ICONIC BRANDS INC 0.99 $EXDI EXACTUS INC 0.95 $GSRX GSRX INDUSTRIES INC 0.95 $MJOGD SECURCAPITAL HOLDINGS CORP 0.9 $LXRP LEXARIA BIOSCIENCE CORP 0.8687 $AXIM AXIM BIOTECHNOLOGIES INC 0.82 $CANN GENERAL CANNABIS CORP 0.805 $ISOLF ISODIOL INTERNATIONAL INC 0.8 $SCNNF STILLCANNA INC 0.7969 $LBUY LEAFBUYER TECHNOLOGIES INC 0.79 $FRLI FRELII INC 0.75 $ETST EARTH SCIENCE TECH INC 0.73 $APPB APPLIED BIOSCIENCES CORP 0.7 $HLSPY HELIOSPECTRA AB 0.662 $SMKC SMOKE CARTEL INC 0.65 $RDDTF RADIENT TECHNOLOGIES INC 0.6175 $NUGS CANNABIS STRATEGIC VENTURES 0.6 $BUDZ WEED INC 0.59 $NGTF NIGHTFOOD HLDGS INC 0.59 $TDNT TRIDENT BRANDS INC 0.57 $TURV TWO RIVERS WATER & FARMING COMP 0.5696 $LXLLF LIVEWELL CANADA INC 0.55 $HRVOF HARVEST ONE CANNABIS INC 0.546 $CTABF CANNTAB THERAPEUTICS LIMITED 0.52 $SRUTF SPROUTLY CANADA INC 0.5152 $MRRCF WAYLAND GROUP CORP 0.5 $WLDFF WILDFLOWER BRANDS INC 0.5 $LHSIF LIBERTY HEALTH SCIENCES INC 0.488 $AGEEF HALO LABS INC 0.487 $SURG SURGE HOLDINGS INC 0.48 $CBDG THC FARMACEUTICALS INC 0.4701 $NXTTF NAMASTE TECHNOLOGIES INC 0.4687 $TNYBF TINLEY BEVERAGE CO INC 0.461 $NBGV NEWBRIDGE GLOBAL VENTURES INC 0.4483 $OCBM PREFERRED COMMERCE INC 0.4375 $VVCIF VIVO CANNABIS INC 0.428 $CIIX CHINESEINVESTORS COM INC 0.4009 $EDXC ENDEXX CORPORATION 0.3826 $NDVAF INDIVA LIMITED 0.3732 $BIOIF BIOME GROW INC 0.3711 $IVITF INVICTUS MD STRATEGIES CORP 0.357 $TGIFF 1933 INDUSTRIES INC 0.354 $CHOOF CHOOM HOLDINGS INC 0.3404 $WCCP WEALTHCRAFT CAPITAL INC 0.3354 $CBSC CB SCIENTIFIC INC 0.32 $PHVAF PHIVIDA HOLDINGS INC 0.3158 $BOSQF THE YIELD GROWTH CORP 0.3014 $CLSH CLS HOLDINGS USA INC 0.3 $PSIQ PROFILE SOLUTIONS INC 0.3 $PVOTF PIVOT PHARMACEUTICALS INC 0.3 $HOPS BETWEEN DANDELIONS INC 0.29 $VCBD VITALIBIS INC 0.2876 $GABLF GABRIELLAS KITCHEN INC 0.2856 $CNBX CANNABICS PHARMACEUTICALS INC 0.2798 $WUHN WUHAN GENERAL GROUP CHINA INC 0.2743 $AHGIF ALTERNATE HEALTH CORP 0.27 $BBRRF BLUEBERRIES MEDICAL CORP 0.27 $FLURF FLUROTECH LTD 0.27 $LDSYF LIFESTYLE DELIVERY SYSTEMS INC 0.269 $CHMJF CHEMISTREE TECHNOLOGY INC 0.2622 http://dlvr.it/R7Tn5Y

[gary-herick]

CANNAPHARMARX ANNOUNCES THE ACQUISITION OF A MINORITY INTEREST IN GN VENTURES

CannaPharmaRx Announces the Acquisition of a Minority Interest in GN Ventures, a Canadian Cannabis Producer, and the Appointment of Dominic Colvin as CEO and Chairman of the Board

Company Continues to acquire Cannabis Grow Capacity in Canada

IRVINE, Calif., Feb 28, 2019 (GLOBE NEWSWIRE via COMTEX) — IRVINE, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) — CannaPharmaRx, Inc. (otc pink sheets:”CPMD”) announced today it has completed the acquisition of a minority interest in GN Ventures, LTD., (“GNC”), an Alberta corporation, engaged in the development of Canadian cannabis cultivation facilities. Under the terms of the stock purchase agreement the Company acquired approximately eighteen (18%) percent of the issued and outstanding securities of GNC for total consideration of 7,998,963 shares of CPMD common stock. Additionally, the Company acquired warrants exercisable to purchase an additional 2,500,000 shares of GN at an exercise price of CAD$1.00 per share.

GNC owns a 60,000 square foot cannabis cultivation and grow facility located on 38 acres in Stevensville, Ontario, Canada. Once completed, GNC estimates annual total production capacity from the Stevensville facility of up to12,500 kilograms of cannabis. When completed, GN believes it will begin cultivation activities and generate its initial harvest by the middle of 2019. Additionally, the plan is to increase cannabis production by building additional cannabis cultivation facilities on the excess land presently owned adjacent to the existing Stevensville facility, provided that additional funding for expansion can be obtained on commercially reasonable terms.

CPMD also appointed Dominic Colvin as Chief Executive Officer, President and Chairman of the Board. Mr. Colvin had previously been CEO, President and a director of CPMD until he resigned to avoid any appearance of conflicts of interest. Mr. Colvin stated, “I am very excited for the growth opportunities at CannapharmaRx. The Company’s objective is to become the premier holder of cannabis producing facilities in Canada. With the previously acquired Hanover property and minority ownership of GN Ventures, we are well on our way to achieving the production and ownership goals of the Company. We intend to acquire additional shares of GN along with other Canadian licensed producers and develop cannabis cultivation facilities which produce high quality cannabis at the lowest operational costs in the industry. Canada is still the place to be for cannabis production and we see a huge demand for years to come from the product we produce.”

About CannaPharmaRx, Inc.

CannaPharmaRx is focused on the acquisition and development of state-of-the-art cannabis grow facilities located in Canada. CPMD has recently completed an initial acquisition of a 48,500 square foot cannabis grow facility presently under development and is currently in discussion with other companies regarding potential acquisitions or business combinations. CannaPharmaRx’s business strategy is to become a leader in high quality and low-cost production of cannabis in Canada through the development, acquisition and enhancement of existing facilities. CannaPharmaRx is presently targeting acquisitions of companies in the final stages of obtaining cannabis licensee applications or those which are nearing revenue generation. CannaPharmaRx is committed to operating high quality facilities utilizing the latest technology in combined heat and power generation to ensure being a low-cost producer of cannabis. CannaPharmaRx is in the process of completing an application to list its common stock on the Canadian Stock Exchange with initial trading anticipated to being during the second quarter of 2019.

Safe Harbor Statement This press release may contain forward looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues and any payment of dividends on our common and preferred stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the Securities and Exchange Commission. Among other matters, CannaPharmaRx, Inc. may not be able to sustain growth or achieve profitability based upon many factors including, but not limited to, general stock market conditions. Reference is hereby made to cautionary statements set forth in the company’s most recent SEC filings. We have incurred and will continue to incur significant expenses in our expansion of our existing and new service lines, noting there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. Additional service offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the various geopolitical locations where we will be providing services, the impact of which cannot be predicted at this time.

Contact Information: Attention info@cannapharmarx.com Telephone 949.652.6838